期刊名称：《临床用药研究》
英文刊名：Clinical Pharmacotherapy Research
国际刊号：ISSN 3105-6741（印刷版）/ ISSN 3105-675X（网络版）
出版模式：金色开放获取（Gold OA），遵循CC BY 4.0许可协议（全文永久免费获取）
出版机构：Macau Sino-Foreign Medical Publishing Limited
出版频率：双月刊
投稿语言：中文（须同时提交英文标题、摘要、关键词、作者姓名及单位信息）

期刊定位
《临床用药研究》是一本立足国际化视野、聚焦医学前沿研究与创新治疗技术的学术期刊。本刊致力于促进基础医学研究与临床实践的有效融合，重点关注创新药物研发、精准医疗、生物技术等前沿方向。我们特别倡导多学科交叉的研究方法，整合分子生物学、临床医学、药物研发及数字医疗等领域的创新成果，为构建现代化医药创新体系提供坚实的学术支持。

征稿范围
本刊欢迎以下研究方向的相关投稿：

创新药物研发与临床评价

精准医疗与个体化治疗

细胞与基因治疗新技术

生物制剂与新型疫苗研发

转化医学与临床前研究

数字医疗与人工智能辅助诊疗

重大疾病创新治疗方案

药物递送系统与制剂技术

罕见病诊疗新进展

医疗政策与药物经济学研究

目标与愿景
本刊旨在打造医学创新研究领域的高水平学术交流平台，推动基础研究成果向临床应用的快速转化。我们致力于营造开放、协作的学术生态，为医学研究者、临床医师及医药研发人员提供高质量的成果发布与学术对话空间，促进全球医学创新事业的协同进步。

数据库索引计划
本刊正在积极申请纳入以下国内外重要学术数据库：

Science Citation Index Expanded (SCIE)

MEDLINE/PubMed

Scopus

Embase

International Pharmaceutical Abstracts

DOAJ (Directory of Open Access Journals)

Google Scholar

百度学术

万方数据

维普资讯

澳门虚拟图书馆

龙源期刊网

超星学术平台

长江文库

新华网学术中国

CNKI中国知网

 

 

Journal Title: Journal of Clinical Medication Research
ISSN: 3105-6741 (Print) / 3105-675X (Online)
Publishing Model: Gold Open Access, under Creative Commons CC BY 4.0 license (Full-text permanently free)
Publisher: Macau Sino-Foreign Medical Publishing Limited
Publication Frequency: Bimonthly
Submission Language: Chinese (must include English title, abstract, keywords, author names, and affiliations)

Journal Scope & Positioning
Journal of Clinical Medication Research is an international academic journal focusing on cutting-edge medical research and innovative therapeutic technologies. It aims to bridge fundamental medical research and clinical practice, with a special emphasis on innovative drug development, precision medicine, and biotechnology. The journal encourages interdisciplinary approaches that integrate innovations in molecular biology, clinical medicine, drug development, and digital healthcare, providing robust academic support for building a modern medical innovation system.

Topics of Interest
Submissions are welcome in the following areas:

Innovative drug development and clinical evaluation

Precision medicine and individualized therapy

Novel cell and gene therapies

Biologics and new vaccine development

Translational medicine and preclinical research

Digital health and AI-assisted diagnosis and treatment

Innovative treatment strategies for major diseases

Drug delivery systems and formulation technologies

Advances in diagnosis and treatment of rare diseases

Healthcare policy and pharmacoeconomics

Aims & Vision
The journal strives to become a leading platform for medical innovation, facilitating the rapid translation of basic research findings into clinical applications. We are committed to fostering an open and collaborative academic environment, providing researchers, clinicians, and pharmaceutical developers with a high-quality forum for disseminating research and engaging in scholarly dialogue, thereby promoting global collaboration in medical innovation.

Indexing Initiatives
The journal is currently applying for inclusion in the following domestic and international databases:

Science Citation Index Expanded (SCIE)

MEDLINE/PubMed

Scopus

Embase

International Pharmaceutical Abstracts

DOAJ (Directory of Open Access Journals)

Google Scholar

Baidu Scholar

WanFang Data

VIP Information

Macau Virtual Library

Dragon Source Journals

Chaoxing Scholar

Yangtze River Database

Xinhuanet Academic China

CNKI (China National Knowledge Infrastructure)